Trade Aspen Pharmacare Holdings Limited - APNHY CFD
Add to favourite- Summary
- Historical Data
- Events
- Ownership
| Spread | 0.26 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.030779% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.013666% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 13.32 |
| Open* | 13.13 |
| 1-Year Change* | N/A |
| Day's Range* | 12.98 - 13.15 |
| 52 wk Range | N/A |
| Average Volume (10 days) | N/A |
| Average Volume (3 months) | N/A |
| Market Cap | N/A |
| P/E Ratio | N/A |
| Shares Outstanding | N/A |
| Revenue | N/A |
| EPS | N/A |
| Dividend (Yield %) | N/A |
| Beta | N/A |
| Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 4, 2022 | 12.98 | -0.17 | -1.29% | 13.15 | 13.21 | 12.97 |
| Feb 3, 2022 | 13.32 | -0.06 | -0.45% | 13.38 | 13.47 | 13.32 |
| Feb 2, 2022 | 13.86 | -0.10 | -0.72% | 13.96 | 14.00 | 13.84 |
| Feb 1, 2022 | 13.96 | -0.10 | -0.71% | 14.06 | 14.09 | 13.93 |
| Jan 31, 2022 | 13.27 | 0.04 | 0.30% | 13.23 | 13.36 | 13.23 |
| Jan 28, 2022 | 12.97 | -0.16 | -1.22% | 13.13 | 13.15 | 12.97 |
| Jan 27, 2022 | 13.23 | -0.06 | -0.45% | 13.29 | 13.33 | 13.19 |
| Jan 26, 2022 | 13.39 | -0.05 | -0.37% | 13.44 | 13.47 | 13.37 |
| Jan 25, 2022 | 12.97 | -0.03 | -0.23% | 13.00 | 13.31 | 12.97 |
| Jan 24, 2022 | 13.21 | -0.03 | -0.23% | 13.24 | 13.27 | 13.03 |
| Jan 21, 2022 | 13.87 | -0.26 | -1.84% | 14.13 | 14.16 | 13.87 |
| Jan 20, 2022 | 13.83 | -0.16 | -1.14% | 13.99 | 14.00 | 13.45 |
| Jan 19, 2022 | 13.24 | -0.04 | -0.30% | 13.28 | 13.30 | 13.24 |
| Jan 18, 2022 | 13.73 | -0.22 | -1.58% | 13.95 | 13.98 | 13.73 |
| Jan 14, 2022 | 14.26 | 0.28 | 2.00% | 13.98 | 14.61 | 13.98 |
| Jan 13, 2022 | 14.10 | -0.41 | -2.83% | 14.51 | 14.67 | 14.10 |
| Jan 12, 2022 | 14.18 | -0.45 | -3.08% | 14.63 | 14.72 | 14.15 |
| Jan 11, 2022 | 13.67 | 0.13 | 0.96% | 13.54 | 14.21 | 13.54 |
| Jan 10, 2022 | 13.62 | -0.32 | -2.30% | 13.94 | 13.96 | 13.62 |
| Jan 7, 2022 | 14.21 | 0.02 | 0.14% | 14.19 | 14.26 | 14.19 |
Aspen Pharmacare Holdings Limited Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Envestnet Asset Management, Inc. | Investment Advisor | 0.0021 | 9350 | 0 | 2022-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Aspen Pharmacare Holdings Limited Company profile
About Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded pharmaceutical company with a commercial footprint covering more than 150 countries and complex manufacturing capabilities in both active pharmaceutical ingredients (APIs) and finished dose form. The Company is focused on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments: Manufacturing and Commercial Pharmaceuticals. The Manufacturing segment relates to the manufacture and sale of APIs and finished dose form products to third-party customers. Its Commercial Pharmaceuticals segment comprises Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis products. It operates approximately 23 manufacturing facilities on six continents. Its manufacturing capabilities cover a wide variety of product types including orals, liquids, steriles, biologicals and APIs.
Financial summary
BRIEF: For the fiscal year ended 30 June 2021, Aspen Pharmacare Holdings Limited revenues increased 12% to RAN37.77B. Net income before extraordinary items increased 42% to RAN4.8B. Revenues reflect Manufacturing segment increase of 36% to RAN9.89B, Sterile Focus Brands segment increase of 11% to RAN10.69B, Developed Europe segment increase of 18% to RAN13.62B, Australasia segment increase of 17% to RAN5.42B.
Equity composition
10/2008, Scrip Issue, 1.75 new shares for every 100 shares held.
| Industry: | Generic Pharmaceuticals |
Aspen Place
9 Rydall Vale Park
DURBAN
KWAZULU-NATAL
ZA
News
S&P 500 & DAX 40 Forecast for the Week Ahead
S&P 500 builds higher after Fed meeting, DAX 40 runs into resistance
16:30, 3 February 2023
FX Weekly Outlook: USD, GBP/USD, USD/JPY Analysis
USD, GBP/USD, USD/JPY forecasts for the week ahead.
15:56, 3 February 2023
GBP/USD drops below 1.23 as BOE comments suggest possible end of rate hikes
Despite increasing rates by 50bps at their February meeting, the messaging from the BOE suggests a dovish tilt an the possible end of rate hikes.
15:37, 2 February 2023
Gold latest: XAU/USD rallies on Fed meeting as traders eye Friday’s jobs data
Gold buyers take advantage of risk on sentiment as they eye Friday's NFP data to assess the likelihood of a soft landing
11:48, 2 February 2023
British Pound (GBP) Outlook: GBP/USD, EUR/GBP Ahead of BoE Rate Decision
Bank of England remains a dovish hiker. GBP at risk of another dovish twist
15:13, 1 February 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com